sernova-white-logo

 

Sernova Corp.

Sernova is developing regenerative, therapeutic medical solutions using a medical device (Cell Pouch) and immune protected therapeutic cells/tissues (i.e. human donor cells, corrected human cells and stem cell-derived cells) to improve the treatment and quality of life of people with chronic metabolic diseases, such as insulin-dependent diabetes, blood disorders including hemophilia, and other diseases treated through cellular production of proteins or hormones missing or in short supply within the body..

OTCQB: SEOVF
IR Website: https://www.sernova.com/investor/
Headquarters: London, Canada

Content provided by Sernova Corp on 2-28-22.


TALK TO MANAGEMENT

The Sernova Corp. management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.

Summary

Investor Presentation

Management Overview

Risks & Disclosures